Skip to main content
    B

    Bristol-Myers Squibb Company (BMY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $61.61
    +0.13 (+0.21%)

    Market Cap: $125.59B

    Last updated: Oct 27, 2026 at 10:41 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    87%(34/39)
    Avg Surprise
    +8.66%
    Streak
    9 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.25
    Range$0.98 - $1.75
    23 analysts
    EPS Revisions
    1
    0
    7d
    1
    8
    30d
    EPS Estimate DriftChange to current
    90d ago$1.61-22.3%
    60d ago$1.73-27.8%
    30d ago$1.73-27.6%
    7d ago$1.34-6.4%
    Current$1.25
    Revenue Consensus
    $12.7B
    Range$12.5B - $12.9B
    21 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.30
    Range$1.88 - $2.78
    27 analysts
    Revenue Consensus
    $14.5B
    Range$13.8B - $15.1B
    26 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.30---
    Sep 26EST
    		-$1.25---
    Jun 26
    Reported Jul 30
    		$2.04$1.59+28.30%Beat+39.7%
    Mar 26
    Reported Apr 30
    		$1.58$1.42+11.27%Beat-12.2%
    Dec 25
    Reported Feb 5
    		$1.26$1.20+5.00%Beat-24.6%
    Sep 25
    Reported Oct 30
    		$1.63$1.52+7.24%Beat-9.4%
    Jun 25
    Reported Jul 31
    		$1.46$1.10+32.73%Beat-29.5%
    Mar 25
    Reported Apr 24
    		$1.80$1.50+20.00%Beat+140.9%
    Dec 24
    Reported Feb 6
    		$1.67$1.47+13.61%Beat+5.0%
    Sep 24
    Reported Oct 31
    		$1.80$1.50+20.00%Beat-10.0%
    Jun 24
    Reported Jul 26
    		$2.07$1.63+26.99%Beat+18.3%
    Mar 24
    Reported Apr 25
    		$-4.40$-4.14-6.28%Miss-314.6%
    Dec 23
    Reported Feb 2
    		$1.59$1.43+11.19%Beat-12.6%
    Sep 23
    Reported Oct 26
    		$2.00$1.77+12.99%Beat+0.5%
    Jun 23
    Reported Jul 27
    		$1.75$1.99-12.06%Miss-9.3%
    Mar 23
    Reported Apr 27
    		$2.05$1.97+4.06%Beat+4.6%
    Dec 22
    Reported Feb 2
    		$1.82$1.73+5.20%Beat-0.5%
    Sep 22
    Reported Oct 25
    		$1.99$1.83+8.74%Beat-0.5%
    Jun 22
    Reported Jul 27
    		$1.93$1.80+7.22%Beat+0.0%
    Mar 22
    Reported Apr 29
    		$1.96$1.90+3.16%Beat+12.6%
    Dec 21
    Reported Feb 4
    		$1.83$1.80+1.67%Beat+25.3%
    Sep 21
    Reported Oct 27
    		$2.00$1.92+4.17%Beat+22.7%
    Jun 21
    Reported Jul 28
    		$1.93$1.90+1.58%Beat+18.4%
    Mar 21
    Reported Apr 29
    		$1.74$1.81-3.87%Miss+1.2%
    Dec 20
    Reported Feb 4
    		$1.46$1.42+2.82%Beat+19.7%
    Sep 20
    Reported Nov 5
    		$1.63$1.49+9.40%Beat+39.3%
    Jun 20
    Reported Aug 6
    		$1.63$1.48+10.14%Beat+38.1%
    Mar 20
    Reported May 7
    		$1.72$1.45+18.62%Beat+56.4%
    Dec 19
    Reported Feb 6
    		$1.22$1.16+5.17%Beat+29.8%
    Sep 19
    Reported Oct 31
    		$1.17$1.07+9.35%Beat+7.3%
    Jun 19
    Reported Jul 25
    		$1.18$1.06+11.32%Beat+16.8%
    Mar 19
    Reported Apr 25
    		$1.10$1.08+1.85%Beat+17.0%
    Dec 18
    Reported Jan 24
    		$0.94$0.85+10.59%Beat+38.2%
    Sep 18
    Reported Oct 25
    		$1.09$0.91+19.78%Beat+45.3%
    Jun 18
    Reported Jul 26
    		$1.01$0.87+16.09%Beat+36.5%
    Mar 18
    Reported Apr 26
    		$0.94$0.85+10.59%Beat+11.9%
    Dec 17
    Reported Feb 5
    		$0.68$0.67+1.49%Beat+7.9%
    Sep 17
    Reported Oct 26
    		$0.75$0.77-2.60%Miss-
    Jun 17
    Reported Jul 27
    		$0.74$0.73+1.37%Beat-
    Mar 17
    Reported Apr 27
    		$0.84$0.74+13.51%Beat-
    Dec 16
    Reported Jan 26
    		$0.63$0.66-4.55%Miss-

    Dividends

    Dividend Metrics

    Forward Yield4.09%
    Forward Annual Dividend$2.52
    Payout Ratio40.27%
    FrequencyQuarterly
    Pay MonthsFeb, May, Aug, Nov

    Growth

    3Y CAGR+4.71%
    5Y CAGR+1.61%
    BMY dividend history and ex-dividend datesRun BMY in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio9.46EV/EBITDA10.62x
    Price/FCF11.00xFCF Yield9.09%
    Profitability
    Profit Margin18.90%Operating Margin34.40%
    ROE46.60%ROIC14.18%
    Financial Health
    Debt/Equity1.93xInterest CoverageN/A
    Current Ratio1.53xQuick Ratio1.38x
    Trading Statistics
    Beta0.18Avg Volume13.11M
    52-Week High$67.9452-Week Low$40.71

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$60.40
    SMA 20$60.22
    SMA 50$62.72
    SMA 200$59.05
    EMA 10$60.91
    EMA 20$60.82
    EMA 50$61.37
    EMA 200$58.43

    MACD

    Line: -0.18Signal: -0.64Hist: 0.45

    ADX

    ADX: 17.5+DI: 27.0-DI: 20.9

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down64.0
    PSAR$57.27

    Bollinger Bands

    Upper Band$63.42
    Lower Band$57.01
    %B Position1065%(Upper)
    Band Width0.72

    RSI (14-Day)

    Neutral
    52.2

    Momentum Oscillators

    Stoch %K79.0
    Stoch %D82.4
    Williams %R-26.6
    ROC (10d)7.0%
    Momentum4.03
    CCI (20d)60.2
    MFI (14d)42.3

    Volatility Measures

    ATR (14d)$1.80(2.9%)
    StdDev (20d)1.60
    Hist Vol36.7%(Moderate)

    Volume Flow

    VWAP$61.59
    OBV177.8M
    AD Line-8.5B
    CMF (20d)-0.256

    Volume Metrics

    Avg Vol (20d)13.1M
    Vol Ratio0.6x
    VWMA (20d)$60.05

    Pivot Points

    R3$63.97
    R2$63.41
    R1$62.44
    Pivot Point$61.88
    S1$60.91
    S2$60.35
    S3$59.38

    Advanced Oscillators

    TSI-3.14
    Ultimate Osc48.7
    KST-43.97

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$12.97B$11.49B$12.50B$12.22B$12.27B$11.20B$12.34B$11.89B$12.20B$11.87B$11.48B$10.97B
    Cost of Revenue$3.73B$3.52B$5.49B$4.07B$4.88B$3.22B$4.84B$3.22B$3.40B$15.88B$3.35B$2.59B
    Gross Profit$9.25B$7.97B$7.01B$8.15B$7.39B$7.98B$7.50B$8.67B$8.80B$-4,016,000,000$8.13B$8.38B
    Operating Expenses$5.22B$4.70B$5.59B$5.15B$5.12B$4.67B$7.02B$6.76B$7.24B$7.42B$6.83B$6.50B
    R&D$2.96B$2.65B$2.59B$2.53B$2.58B$2.26B$3.19B$2.37B$2.90B$2.69B$2.48B$2.24B
    SG&A$1.83B$1.62B$2.18B$1.79B$1.71B$1.58B$2.14B$1.98B$1.93B$2.37B$2.07B$2.00B
    Operating Income$4.03B$3.27B$1.42B$3.01B$2.27B$3.31B$480.00M$1.91B$1.56B$-11,435,000,000$1.30B$1.88B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$31.00M$0$0$493.00M$338.00M$305.00M$234.00M$273.00M$81.00M$0$0
    Income Before Tax$4.09B$3.24B$1.47B$3.11B$1.77B$2.97B$175.00M$1.68B$1.29B$-11,516,000,000$1.67B$2.14B
    Income Tax Expense$770.00M$561.00M$384.00M$919.00M$460.00M$509.00M$99.00M$461.00M$-398,000,000$392.00M$-88,000,000$203.00M
    Net Income$3.32B$2.68B$1.08B$2.19B$1.31B$2.46B$76.00M$1.22B$1.68B$-11,908,000,000$1.76B$1.93B
    EBITDA$4.68B$3.83B$2.45B$4.13B$2.78B$3.98B$2.06B$4.27B$3.88B$-8,984,000,000$4.14B$4.57B
    EBIT$4.09B$3.24B$1.47B$3.11B$1.77B$2.97B$175.00M$1.68B$1.29B$-11,516,000,000$1.67B$2.14B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Pfizer: The 6% Yield Hiding Behind a Post-Pandemic Hangover

    Pfizer trades at 9.6x forward earnings with 6.3% yield; non-COVID portfolio grew 6% operationally in 2025, but market still prices post-pandemic discount GAAP payout ratio of 98.8% is misleading; on adjusted EPS of $3.22...

    Glenn Ford
    •
    2/12/26
    •
    178
    Income Investing, value investing
    Also mentions:
    MRKBMYGILDABBV

    Government Contracts

    Gov Obligations (TTM)
    $8.25M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    4.5%
    Active Awards
    71
    New Awards (TTM)
    65
    Avg Remaining Term
    2.3 mo

    Top agency: Department of Veterans Affairs at 99.7% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25226N0198Department of Veterans AffairsDepartment of Veterans Affairs$848445Dec 31, 2025
    36C24926F0096Department of Veterans AffairsDepartment of Veterans Affairs$378650Mar 13, 2026
    36C24526N0290Department of Veterans AffairsDepartment of Veterans Affairs$365117Jan 29, 2026
    36C26226N0738Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 30, 2026
    36C24926N0591Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 18, 2026
    36C24926N0590Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 18, 2026
    36C24926N0589Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 18, 2026
    36C24926N0433Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 2, 2026
    36C24926N0543Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 22, 2026
    36C24926N0528Department of Veterans AffairsDepartment of Veterans Affairs$364139Jun 26, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Ultragenyx Pharmaceutical (RARE) Set to Post Quarterly Earnings on Tuesday

    Ultragenyx Pharmaceutical (RARE) is scheduled to release its Q3 2026 earnings after market close on Tuesday, November 3rd...

    MarketBeat•10/27/26•Neutral

    Glj Research Issues Pessimistic Forecast for Enphase Energy (NASDAQ:ENPH) Stock Price

    GLJ Research has reduced its price target for Enphase Energy (NASDAQ:ENPH) from $24.47 to $21.49, maintaining a "sell" rating and indicating a potential 29% downside. This comes amidst cautious analyst sentiment...

    MarketBeat•10/27/26•Somewhat-Bullish

    Sphere Entertainment (SPHR) Set to Announce Earnings on Tuesday

    Sphere Entertainment (SPHR) is scheduled to release its Q3 2026 earnings before the market opens on Tuesday, November 3rd. Analysts are predicting a loss of $1.59 per share on revenue of $273.21 million. The company's...

    MarketBeat•10/27/26•Neutral

    Sphere Entertainment (NYSE:SPHR) Stock Price Target Cut by Morgan Stanley

    Morgan Stanley reduced its price target for Sphere Entertainment (NYSE:SPHR) from $170 to $150, but maintained an "overweight" rating...

    MarketBeat•10/27/26•Somewhat-Bullish

    Occidental Petroleum Corporation (NYSE:OXY) Shares to Pay Quarterly Dividend of $0.28

    Occidental Petroleum Corporation (NYSE:OXY) has declared a quarterly dividend of $0.28 per share, payable on January 15, 2027, to shareholders of record on December 10...

    MarketBeat•10/27/26•Neutral

    BMY Valuation and Fair Value

    P/E
    9.5x
    Forward P/E
    9.9x
    EV/EBITDA
    10.6x
    P/FCF
    11.0x
    PEG
    2.4x
    P/B
    5.6x
    See GNG's fair value

    BMY Profitability: Margins, ROIC and FCF

    Gross margin
    65.9%
    Operating margin
    34.4%
    Net margin
    18.9%
    ROIC
    14.2%
    ROE
    46.6%
    FCF yield
    9.1%

    BMY Competitors

    CompanyTicker
    Vertex Pharmaceuticals IncVRTX
    Medtronic PLCMDT
    Intuitive Surgical IncISRG
    CVS Health CorpCVS
    Danaher CorporationDHR
    Stryker CorporationSYK
    Pfizer IncPFE
    McKesson CorporationMCK

    Sector: Healthcare

    BMY Analyst Ratings

    Consensus
    Hold
    Analysts
    28
    Strong Buy
    3
    Buy
    7
    Hold
    17
    Sell
    1
    Strong Sell
    0

    BMY Bull Case vs Bear Case

    Bull case

    • BMY beat EPS estimates in 100.0% of its last 8 reported quarters.

    BMY Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    17.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.25
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 8 down

    BMY Dividend

    Forward yield
    4.1%
    Payout ratio
    40.3%
    3Y DPS growth
    4.7%
    5Y DPS growth
    1.6%
    Pay months
    Feb, May, Aug, Nov
    BMY dividend history

    Frequently Asked Questions About BMY

    What is BMY's current dividend yield?

    Bristol-Myers Squibb Company (BMY) has a forward dividend yield of 4.09%.

    Does BMY pay dividends?

    Yes, Bristol-Myers Squibb Company pays dividends with a forward dividend yield of 4.09%.

    What is BMY's P/E ratio?

    Bristol-Myers Squibb Company has a price-to-earnings (P/E) ratio of 9.46.

    What is BMY's market cap?

    Bristol-Myers Squibb Company (BMY) has a market capitalization of $125.59B with a current stock price of $61.61.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In